Company
Generate Biomedicines
Generate Biomedicines has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| GB-0895 | Phase 3 | Severe Asthma |
Latest
No recent events.
Follow Generate Biomedicines on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.